Yvonne Mårtensson proposed as Board member of Elos AB

The Nomination Committee of Elos AB will propose that the Annual General Meeting re-elect Board members Stig-Arne Blom (Chairman of the Board), Agneta Bengtsson Runmarker, Jeppe Magnusson, Mats Nilsson and Thomas Öster. In addition, the Nomination Committee will propose that Yvonne Mårtensson be elected as a new Board member. The current members Göran Brorsson and Erik Löwenadler have announced that they will be declining re-election.

Yvonne Mårtensson has an M.Sc. degree from Linköping Technical University. She has held a large number of positions in international marketing and sales of medical technical and analytical instruments in Europe, the US and Asia. Between 1998 and 2014, she was MD of Cellavision AB, which she led from when it was a concept-based start-up company until it developed into a global listed company active in the analysis of blood and other bodily fluids.

The Nomination Committee at Elos represents approximately 66% of all votes in the company. The other proposals will be announced in the Notification to the Annual General Meeting that is scheduled to be published on 27 March.

Lidköping, 26 February, 2015

Elos AB (publ)

For further information, please contact: Bengt Belfrage, Chairman of the Nomination Committee, telephone 46 (0)705 16 32 45, E-post bengt@belfrage.se

For additional information Elos Group, visit www.elos.se  

The information of this press release is of the kind that Elos AB (publ) has to make public according to the Securities Market Act and/or the Financial Instruments Trading Act. The information was made public on 26 February, 2015 at 08:00 a.m. (CET).

Tags:

About Us

Elos Medtech is one of Europe's leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental Implant Systems, Diagnostics, Medical Devices and Trauma & Spine. Elos Medtech employs more than 500 people worldwide and generates revenue that exceeds MSEK 550. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.

Subscribe

Documents & Links